Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel maintains a Buy rating on Dolby Laboratories (NYSE:DLB) with a $98 price target, indicating a positive outlook on the stock.

May 03, 2024 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt maintains a Buy rating on Dolby Laboratories with a $98 price target, reflecting a positive sentiment towards the company's stock.
The maintenance of a Buy rating and a high price target by a reputable analyst like Steve Frankel suggests a strong confidence in Dolby Laboratories' future performance. This endorsement is likely to influence investor sentiment positively, potentially driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100